InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Cline Darren S, Directeur Commercial Principal des États-Unis. Insider active across 2 companies, notably GW Pharmaceuticals PLC. In total, 5 reports have been recorded. Total volume traded: €167k. The latest transaction was filed on 31 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
066,831 shares0
Common Stock
SEC:0001140361-22-012914:0·
€83,25710,000 shares@ €8.3257100.0% of flow
Common Stock
SEC:0000899243-21-047525·
Ideal exit: 4 Sept 2022 (T+270)
€83,25710,000 shares@ €8.32570.058% mcap50.0% of flow
Common Stock
SEC:0000899243-21-047525:0·
Ideal exit: 4 Sept 2022 (T+270)
5,556 shares
Ordinary Shares
SEC:0000899243-21-018670·
5,556 shares
Ordinary Shares
SEC:0000899243-21-018670:0·
5 of 5 declarations
About Cline Darren S
Darren S. Cline is the U.S. Chief Commercial Officer and a Board Member at GW Pharmaceuticals PLC and Pyxis Oncology, Inc. In these roles, he is responsible for the strategic and operational leadership of the companies, which specialize in the pharmaceutical sector. Darren plays a key role in growth and innovation, ensuring that the firms meet market needs.
